Amgen Inc (NASDAQ:AMGN)

249.12
Delayed Data
As of Jul 10
 -2.54 / -1.01%
Today’s Change
173.12
Today|||52-Week Range
264.97
+3.34%
Year-to-Date
Here's Why Adaptive Biotechnologies Soared 61.7% in the First Half of 2020
Jul 09 / MotleyFool.com - Paid Partner Content
Amgen's Enbrel Patents to Be Upheld Through 2029
Jul 01 / MotleyFool.com - Paid Partner Content
Amgen's Win, Netflix's Hire Send Nasdaq Higher
Jul 01 / MotleyFool.com - Paid Partner Content
3 Reasons Why Vertex Is a Great Stock to Buy and Hold for the Long Term
Jun 30 / MotleyFool.com - Paid Partner Content
Why Amgen Shares Jumped Today
Jul 01 / MotleyFool.com - Paid Partner Content
Is Amgen a Great Dividend Stock?
Jun 30 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close251.66
Today’s open250.34
Day’s range247.18 - 250.81
Volume90,144
Average volume (3 months)3,240,255
Market cap$146.5B
Data as of 3:59pm ET, 07/10/2020

Growth & Valuation

Earnings growth (last year)+2.07%
Earnings growth (this year)+4.98%
Earnings growth (next 5 years)+7.07%
Revenue growth (last year)-2.13%
P/E ratio19.5
Price/Sales6.31
Price/Book15.23

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+1.66+2.22%
ILMNIllumina Inc-2.36-0.63%
BIIBBiogen+0.19+0.07%
MRNAModerna Inc-2.40-3.69%
Data as of 4:57pm ET, 07/10/2020

Financials

Next reporting dateJuly 29, 2020
EPS forecast (this quarter)$3.80
Annual revenue (last year)$23.3B
Annual profit (last year)$7.8B
Net profit margin33.71%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Thousand Oaks, California

Forecasts